NASDAQ: GPCRStructure Therapeutics Inc Stock Ownership - Who owns Structure Therapeutics?
Insider buying vs selling
Have Structure Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Crespo Blas Coll | Med | 2026-09-18 | 10,626 | $11.67 | $124.01kSell |
| Xichen Lin | CSci | 2026-09-01 | 17,817 | $0.34 | $6.06kBuy |
| Xichen Lin | CSci | 2026-08-18 | 11,817 | $0.34 | $4.02kBuy |
| Xichen Lin | CSci | 2026-08-04 | 11,817 | $0.34 | $4.02kBuy |
| Xichen Lin | CSci | 2026-07-14 | 23,634 | $0.34 | $8.04kBuy |
| Xichen Lin | CHIEF SCIENTIFIC OFFICER | 2026-06-25 | 23,634 | $0.34 | $8.04kBuy |
| Jun Yoon | CHIEF FINANCIAL OFFICER | 2026-03-03 | 22,305 | $20.99 | $468.18kSell |
| Ashley Hall | Chief Development Officer | 2026-03-03 | 4,836 | $20.99 | $101.51kSell |
| Xichen Lin | CHIEF SCIENTIFIC OFFICER | 2026-03-03 | 18,735 | $20.99 | $393.25kSell |
| Yingli Ma | CHIEF TECHNOLOGY OFFICER | 2026-03-03 | 11,313 | $20.99 | $237.46kSell |
GPCR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GPCR insiders and whales buy or sell their stock.
GPCR Shareholders
What type of owners hold Structure Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fil Ltd | 3.03% | 6,473,761 | $232.60M | Insider |
| Fmr LLC | 2.35% | 5,031,181 | $180.77M | Insider |
| Ramy Farid | 1.52% | 3,260,495 | $117.15M | Insider |
| Jun Yoon | 1.38% | 2,956,242 | $106.22M | Insider |
| Raymond C. Stevens | 1.38% | 2,956,179 | $106.22M | Insider |
| Crespo Blas Coll | 0.12% | 258,228 | $9.28M | Insider |
| Bvf Partners L P | 0.11% | 241,755 | $8.69M | Insider |
| Xichen Lin | 0.11% | 228,960 | $8.23M | Insider |
| Matthew Lang | 0.09% | 184,614 | $6.63M | Insider |
| Ashley Hall | 0.07% | 155,187 | $5.58M | Insider |
GPCR vs Biotech Stocks
Structure Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.